Neurocognitive functioning and functional connectivity in meningioma patients: a magnetoencephalography study

Neurocognitive functioning and functional connectivity in meningioma patients: a magnetoencephalography study - Cognition & functional connectivity in meningioma patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30843

Enrollment

Registered

2007-10-11

Start date

2007-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Adult (> 18 years), (2) histologically proven meningioma WHO grade I, (3) no clinical or radiological signs of tumor progression for at least one year prior to inclusion date, (4) end of treatment at least one year prior to inclusion, and (5) written informed consent.

Exclusion criteria

Exclusion criteria: (1) Use of centrally acting drugs, including corticosteroids, other than antiepileptic drugs, (2) a medical condition that interferes with normal cognitive functioning, (3) cerebrovascular pathology, (4) congenital CNS malformations, (5) multiple sclerosis, (6) Parkinson*s disease, (7) psychiatric disease or symptoms, (8) optic nerve meningiomas, (9) insufficient mastery of the Dutch language, and (10) inability to communicate adequately.

Design outcomes

Primary

Measure	Time frame
Main study parameters are cognitive functioning (measured by an extensive neuropsychological test battery) and MEG-measures of functional connectivity (synchronization likelihood).	—

Secondary

Measure	Time frame
n.v.t.	—

Countries

Netherlands

Outcome results